The pandemic made one lesson permanent: a facility that cannot guarantee its own oxygen cannot guarantee care. For many health systems, that has turned on-site oxygen generation from a nice-to-have into a strategic decision.
How the options differ
Cylinder and bulk-liquid supply is low on capital cost and simple to start, but it ties you to deliveries, price movements and storage handling — and it strains exactly when demand spikes. On-site PSA plants generate medical-grade oxygen continuously from ambient air, cutting delivery dependence and stabilising long-run cost.
What should actually decide it
- Consumption — daily and peak oxygen demand across wards, theatres and critical care.
- Reliability requirement — how catastrophic a supply interruption would be.
- Site conditions — space, power and civil works for a plant room.
- Redundancy — duplex plants and back-up so maintenance never stops flow.
- Total cost over time — capex plus energy, servicing and top-ups, not headline price alone.
- Maintenance capacity — who keeps it running, and how fast they respond.
The point most facilities miss
A plant is one component of a system. Generation, storage, distribution and monitoring have to be engineered together — or the investment underdelivers. Oxygen is an infrastructure decision, not a product purchase.